Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

August 2, 2017

Relizorb Improves Nutritional Status in Tube-Fed CF Patients, Study Finds

News

Treatment with Alcresta Therapeutics’ product Relizorb effectively increased fat absorption in patients with cystic fibrosis (CF) receiving enteral tube feeding who have trouble breaking down and absorbing these molecules. This ... Read more

July 26, 2017July 26, 2017

SmartVest Now Comes with Built-in Wireless Technology, Assisting Therapy Management

cystic fibrosis, News

Electromed recently launched a SmartVest Connect wireless technology to complement the SmartVest SQL, a technology that allows doctors and patients with certain lung diseases, such as cystic fibrosis or bronchiectasis, to have ... Read more

July 21, 2017July 21, 2017

Boomer Esiason Foundation Taking Its Bike to Breathe CF Awareness Effort to Europe

cystic fibrosis, News

In September 2016, Jerry Cahill and Emily Schaller joined a high-profile effort to persuade cystic fibrosis patients like themselves to cycle to improve their health. The title of the event ... Read more

July 14, 2017July 14, 2017

SNSP113 Gives Antibiotics More Punch Against Bacteria Often Seen in Cystic Fibrosis, Study Find

cystic fibrosis, News

Synspira’s SNSP113 gives antibiotics more punch against the Burkholderia cepacia infections that cystic fibrosis patients experience, a study reports. The research, published in PLoS One, was titled “Novel glycopolymer sensitizes Burkholderia cepacia complex isolates ... Read more

July 10, 2017July 10, 2017

How Certain Bacteria Resist Antibiotics to Become Virulent in CF and Other Diseases Focus of Thesis

cystic fibrosis, News

A deeper understanding of how bacteria like Pseudomonas aeruginosa acts and survives in people despite antibiotic treatment was the focus of a doctoral thesis, along with a recommendation for antibiotic combinations that might work ... Read more

July 6, 2017July 6, 2017

Proteostasis Asks FDA to Help It Advance PTI-808 as Cystic Fibrosis Combo Treatment

News

Proteostasis Therapeutics has filed an Investigational New Drug application with the U.S. Food and Drug Administration for PTI-808 as a treatment for cystic fibrosis. PTI-808 promotes the activity of the cystic ... Read more

May 17, 2017May 17, 2017

Spyryx to Present Two Studies on SPX-101’s Ability to Treat Cystic Fibrosis by Clearing Airway Mucus

cystic fibrosis, News

Spyryx Biosciences will present two studies in Washington this week on SPX-101‘s ability to treat cystic fibrosis by clearing mucus from airways. One of the preclinical-trial studies it will discuss at ... Read more

April 12, 2017April 12, 2017

Tα1 Molecule Reverses Cystic Fibrosis Tissue Defects in Mice, Study Shows

cystic fibrosis, News

The naturally occurring molecule thymosin α1 (Tα1) reversed tissue defects in mice with cystic fibrosis (CF) and in human cells that contained a mutation associated with the disease, according to ... Read more

April 7, 2017April 7, 2017

Spyryx Biosciences Presents Novel Data on CF Therapy SPX-101 at 2 Scientific Meetings

News

Spyryx Biosciences presented new data and updates on its cystic fibrosis (CF) treatment SPX-101 at two recent events: the European Cystic Fibrosis Society Basic Science Conference, which took place March 29-April 1 ... Read more

March 30, 2017March 30, 2017

Stem Cell Therapy May Reduce Lung Inflammation Associated with Cystic Fibrosis

cystic fibrosis, News

Stem cell therapy may reduce lung inflammation in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), according to preliminary results of a pre-clinical-trial study. The findings, presented at this ... Read more

Join our email list!